All In Biotech

Drug Trial Radar · NCT01096186

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Nov 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

617

Actual

Start

Mar 2010

Primary completion

Oct 2011

Study completion Oct 2011

Sponsor

Lead sponsor
Impax Laboratories, LLCIndustry
Sponsor type
Industry
First posted
Mar 31, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.

Conditions

  • Parkinson's Disease

Interventions

  • IPX066 95 mgDrug

    23.75 - 95 mg CD-LD capsules

  • IPX066 145 mgDrug

    36.25 - 145 mg CD-LD capsules

  • IPX066 195 mgDrug

    48.75 - 195 mg CD-LD capsules

  • IPX066 245 mgDrug

    61.25 - 245 mg CD-LD capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Sum of UPDRS Part II + UPDRS Part IIITime frame: 9 months

Locations

81 sites in 10 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Mohammed Ali Parkinson's Center

    Phoenix, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

  • Clinical Trials Inc.

    Little Rock, Arkansas

  • Coastal Neurological Medical Group

    La Jolla, California

  • Coordinated Clinical Research

    La Jolla, California

  • The Parkinson's Institute

    Sunnyvale, California

  • Collaborative NeuroScience Network, Inc.

    Torrance, California

  • Bradenton Research Center, Inc.

    Bradenton, Florida

  • Sunrise Clinical Research

    Hollywood, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Charlotte Neurological Services Parkinson's Disease Treatment Center of S.W. Florida

    Port Charlotte, Florida

  • Suncoast Neuroscience Associates, Inc.

    St. Petersburg, Florida

  • University of South Florida, Parkinson's Disease and Movement Disorders Center

    Tampa, Florida

  • Medical College of Georgia, Movements Disorders Clinic

    Augusta, Georgia

  • Movement Disorder Center at Idaho Elks Rehabilitation Hospital

    Boise, Idaho

  • Northwestern University, Feinberg School of Medicine, Dept. of Neurology

    Chicago, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • Iowa Methodist Medical Center

    Des Moines, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Quest Research Institute

    Bingham Farms, Michigan

  • Struthers Parkinson's Center

    Golden Valley, Minnesota

  • UMDNJ Robert Wood Johnson Medical Center, Department of Neurology

    New Brunswick, New Jersey

  • Albany Medical College, Parkinson's Disease and Movement Disorders Center

    Albany, New York

  • David L. Kreitzman, MD, P.C.

    Commack, New York

  • Columbia University Neurological Institute

    New York, New York

  • Institute for Human Performance

    Syracuse, New York

  • Duke University Medical Center Movement Disorders Center

    Durham, North Carolina

  • University Neurology, Inc.

    Cincinnati, Ohio

  • University of Toledo

    Toledo, Ohio

  • The Movement Disorder Clinic of Oklahoma

    Tulsa, Oklahoma

  • Medical University of South Carolina

    Charleston, South Carolina

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • South Puget Sound Neurology

    Tacoma, Washington

  • Wisconsin Institute for Neurologic and Sleep Disorders

    Milwaukee, Wisconsin

  • London Health Sciences Centre, University Hospital

    London, Ontario, Canada

  • Parkinson's & Neurodegenerative Disorder Clinic

    Ottawa, Ontario, Canada

  • Ottawa Hospital Civic Site

    Ottawa, Ontario, Canada

  • Quebec Memory & Motor Skills Disorders Clinic

    Québec, Quebec, Canada

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.